Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2957488945;88946;88947 chr2:178554627;178554626;178554625chr2:179419354;179419353;179419352
N2AB2793384022;84023;84024 chr2:178554627;178554626;178554625chr2:179419354;179419353;179419352
N2A2700681241;81242;81243 chr2:178554627;178554626;178554625chr2:179419354;179419353;179419352
N2B2050961750;61751;61752 chr2:178554627;178554626;178554625chr2:179419354;179419353;179419352
Novex-12063462125;62126;62127 chr2:178554627;178554626;178554625chr2:179419354;179419353;179419352
Novex-22070162326;62327;62328 chr2:178554627;178554626;178554625chr2:179419354;179419353;179419352
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: R
  • RefSeq wild type transcript codon: CGT
  • RefSeq wild type template codon: GCA
  • Domain: Fn3-103
  • Domain position: 42
  • Structural Position: 43
  • Q(SASA): 0.1345
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
R/C rs200513274 -1.687 1.0 N 0.885 0.374 None gnomAD-2.1.1 2.60645E-04 None None None None N None 1.23957E-04 2.83E-05 None 0 4.10298E-04 None 2.61455E-04 None 0 3.98624E-04 2.80899E-04
R/C rs200513274 -1.687 1.0 N 0.885 0.374 None gnomAD-3.1.2 2.89283E-04 None None None None N None 1.20691E-04 0 0 0 7.72201E-04 None 0 0 5.14555E-04 0 0
R/C rs200513274 -1.687 1.0 N 0.885 0.374 None 1000 genomes 1.99681E-04 None None None None N None 0 0 None None 1E-03 0 None None None 0 None
R/C rs200513274 -1.687 1.0 N 0.885 0.374 None gnomAD-4.0.0 4.75884E-04 None None None None N None 1.06627E-04 0 None 0 3.79007E-04 None 1.56265E-05 0 5.8059E-04 3.51363E-04 4.00128E-04
R/G rs200513274 -2.568 1.0 N 0.783 0.466 0.614107689767 gnomAD-2.1.1 4.02E-06 None None None None N None 0 0 None 0 0 None 3.27E-05 None 0 0 0
R/G rs200513274 -2.568 1.0 N 0.783 0.466 0.614107689767 gnomAD-4.0.0 2.05251E-06 None None None None N None 0 0 None 0 0 None 0 0 1.79885E-06 1.15937E-05 0
R/H rs111727915 -2.472 1.0 N 0.787 0.404 None gnomAD-2.1.1 5.3912E-04 None None None None N None 2.06629E-03 9.89819E-04 None 1.74149E-03 0 None 3.27E-05 None 4E-05 3.12627E-04 8.4246E-04
R/H rs111727915 -2.472 1.0 N 0.787 0.404 None gnomAD-3.1.2 8.74057E-04 None None None None N None 2.05096E-03 1.30959E-03 0 1.72911E-03 0 None 0 0 3.0866E-04 0 4.78469E-04
R/H rs111727915 -2.472 1.0 N 0.787 0.404 None 1000 genomes 9.98403E-04 None None None None N None 1.5E-03 2.9E-03 None None 0 1E-03 None None None 0 None
R/H rs111727915 -2.472 1.0 N 0.787 0.404 None gnomAD-4.0.0 3.14762E-04 None None None None N None 1.9855E-03 9.83071E-04 None 1.58773E-03 0 None 1.56226E-05 1.32013E-03 1.70361E-04 6.58733E-05 5.9219E-04

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
R/A 0.98 likely_pathogenic 0.9823 pathogenic -2.153 Highly Destabilizing 0.999 D 0.561 neutral None None None None N
R/C 0.6076 likely_pathogenic 0.6211 pathogenic -1.928 Destabilizing 1.0 D 0.885 deleterious N 0.472030802 None None N
R/D 0.9984 likely_pathogenic 0.9985 pathogenic -0.845 Destabilizing 1.0 D 0.871 deleterious None None None None N
R/E 0.974 likely_pathogenic 0.9746 pathogenic -0.633 Destabilizing 0.999 D 0.581 neutral None None None None N
R/F 0.993 likely_pathogenic 0.9934 pathogenic -1.386 Destabilizing 1.0 D 0.892 deleterious None None None None N
R/G 0.9637 likely_pathogenic 0.9673 pathogenic -2.485 Highly Destabilizing 1.0 D 0.783 deleterious N 0.488071142 None None N
R/H 0.7671 likely_pathogenic 0.7586 pathogenic -2.25 Highly Destabilizing 1.0 D 0.787 deleterious N 0.496971912 None None N
R/I 0.9817 likely_pathogenic 0.9822 pathogenic -1.186 Destabilizing 1.0 D 0.901 deleterious None None None None N
R/K 0.448 ambiguous 0.4362 ambiguous -1.304 Destabilizing 0.998 D 0.483 neutral None None None None N
R/L 0.947 likely_pathogenic 0.9538 pathogenic -1.186 Destabilizing 1.0 D 0.783 deleterious N 0.489121099 None None N
R/M 0.936 likely_pathogenic 0.9397 pathogenic -1.659 Destabilizing 1.0 D 0.869 deleterious None None None None N
R/N 0.994 likely_pathogenic 0.9939 pathogenic -1.205 Destabilizing 1.0 D 0.725 prob.delet. None None None None N
R/P 0.9995 likely_pathogenic 0.9996 pathogenic -1.499 Destabilizing 1.0 D 0.883 deleterious N 0.514822678 None None N
R/Q 0.4785 ambiguous 0.4711 ambiguous -1.138 Destabilizing 1.0 D 0.705 prob.neutral None None None None N
R/S 0.9932 likely_pathogenic 0.9935 pathogenic -2.187 Highly Destabilizing 1.0 D 0.795 deleterious N 0.51222762 None None N
R/T 0.9837 likely_pathogenic 0.9837 pathogenic -1.767 Destabilizing 1.0 D 0.781 deleterious None None None None N
R/V 0.9776 likely_pathogenic 0.9784 pathogenic -1.499 Destabilizing 1.0 D 0.88 deleterious None None None None N
R/W 0.9171 likely_pathogenic 0.9242 pathogenic -0.837 Destabilizing 1.0 D 0.875 deleterious None None None None N
R/Y 0.9715 likely_pathogenic 0.9734 pathogenic -0.732 Destabilizing 1.0 D 0.909 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.